Login
$IBG
$0.96 -$0.07 (6.37%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q4 FY2025
As of Dec 31, 2025
Q4 FY2024
As of Dec 31, 2024
Assets
Current assets:
Cash
Accounts receivable, net
Inventories, at cost
Prepaid expenses
Current portion of loan to shareholders
Prepaid expenses and other current assets
Total current assets
Deposits
Finance right of use asset, net
Operating right of use asset, net
Non-current portion of loan to shareholders
Equipment, net
Intangible assets, net
Prepaid distribution cost
Deferred tax asset
Total assets
Liabilities and Stockholders' Equity (Deficit)
Current liabilities:
Accounts payable and accrued expenses
Deferred revenue
Notes and loans payable - related party
Notes and loans payable
Operating lease liability, current portion
Other liabilities
Total current liabilities
Long-term liabilities:
Accrued employee benefits, non-current
Notes and loans payable, less current portion
Operating lease liability, less current portion
Total long-term liabilities
Total liabilities
Stockholders' equity (deficit):
Ordinary shares, no par value; no authorization limit; 694,066 and 346,954 shares issued and outstanding at December 31, 2025 and 2024, respectively
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders' equity (deficit)
Total liabilities and stockholders' equity (deficit)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support